In Loving Memory of Kate articles

Can Women Wait for First Colonoscopy?

Evidence that adenomas (polyps) develop later in women than in men has experts asking whether women can wait until they are sixty to be screened for colorectal cancer. Some disagree.  They point out that while women’s risk is smaller in their fifties that possibility still exists.  Obesity, being African American, and having diabetes also increases risk of adenomas and potentially cancer in women. Dr. Sidney Winawer from Memorial Sloan Kettering Cancer Center told MedPage Today, My opinion has been, and still is, that although the risk in women is lower, it is not zero. The old message was that colon cancer was a man’s disease. We have to be careful

Goodbye My Friend

We passed too often in the night of this disease, Pat Steer and I. We made plans that sometimes turned out too hard to keep. One of our plans was to get together at the Creekside, to talk books and dogs, but she got sicker, and I was suddenly very sick. We planned for phone calls that fell through and for my driving over for sit-down talks at her condo that I never had enough time for. I wanted to have her tell me how to to cope with a disease that neither of us wanted. She lived with stage IV rectal cancer for 8 years. After five years of

FDA Okays New Low Volume Colonoscopy Prep

The FDA has approved Prepopik, a powder mixture of sodium picosulfate, magnesium oxide, and citric acid, as a colonoscopy prep. The new prep is a low volume drink that consists of two 5 ounces of water and two packets of laxative chemicals that need to be mixed together. In two clinical trials it was as effective as polyethylene glycol plus electrolytes (PEG+E) solution and two 5-milligram bisacodyl tablets. (HalfLytely for Bowel Preparation for Colonoscopy) and (HalfLytely for Bowel Preparation for Colonoscopy – Split Dose) The new Prepopik reduces the amount of treatment liquid the patient must drink from a little over 2 quarts (67 ounces) to 10 ounces. However, after

Where in the World is Kate Murphy?

Those of you who are regular readers of Research News may have noticed I haven’t been around for the past few weeks. I’ve been busy dealing with some serious health issues — getting scanned and scoped and pumped full of chemo. Strangely, my early stage colon cancer which was surgically removed five years ago has recurred. Strange because it was stage II, Lynch-related, and five years in the past, all usually positive factors for cancer not coming back. But after three months of chasing pain in my side thinking bowel obstruction, new primary Lynch-related urethelial cancer, even pancreatic cancer at one point, a biopsy of a lymph node proved to

National Cancer Survivor's Day — June 3

What a way to celebrate National Colorectal Cancer Survivor’s Day – a huge meeting of researchers, cancer research advocates, healthcare professionals who take care of people with cancer at the Annual Meeting of the Association of Clinical Oncology in Chicago. Over 12 million people in the US have been diagnosed with cancer and are alive, over 1 million with colon or rectal cancer.

Avastin Second-Line Treatment Improves Survival Time

Continuing Avastin into second-line chemotherapy for advanced colorectal cancer when tumors begin to grow larger or new tumors appear (progression) improves both survival time and the time until further progression according to Phase III clinical trial results that will be reported this Sunday morning, June 3, at ASCO 2012 in Chicago Study results were previewed in an ASCO Press Briefing yesterday. Overall survival time increased by 19% with Avastin compared to a switch to a new chemotherapy alone. Time until cancer progressed fell 32%. Serious side effects remained similar.

Dr. Edith Mitchell Honored by ASCO

Edith Peterson Mitchell, MD, FACP has been honored with the 2012 ASCO Humanitarian Award. The Award is given to an oncologist who goes beyond the call of duty to provide outstanding patient care both professionally and and as a volunteer. Dr. Mitchell is a clinical professor in the department of Medical Oncology and a program leader of Gastrointestinal Oncology at Jefferson Medical College of Thomas Jefferson University. At the Kimmel Cancer Center she directs the KCC Center to Eliminate Cancer Disparities.

Watch Out for Fake Adderall

The FDA is warning consumers about counterfeit Adderall advertised on the Internet. The fake pills are not made by Teva Pharmaceuticals, contain none of the active Adderall ingredients, and instead have ingredients that may be dangerous. Adderall is a stimulant approved by the FDA to treat attention deficit disorder and narcolepsy, but is occasionally prescribed off-label for cancer-related fatigue. It is currently listed in shortage due to manufacturing problems at Teva.

Have They Found a Better Colonoscopy Prep?

Ask almost anyone after their first colonoscopy, and they’ll tell you, “The procedure was nothing, but the prep was awful.” Now patients are reporting that combining MiraLAX®, an over-the-counter laxative, with 2 quarts of Gatorade tastes better and is easier to take than the standard 4-quart Golytely colonoscopy preparation. In a randomized clinical trial , almost 100 percent said they would repeat it again, compared to 1 out of 4 who wouldn’t take GoLYTELY® in the future. In addition, doctors found no differences in how thoroughly the two preps clean the colon. Splitting the dose between the night before the colonoscopy and the morning of the procedure did improve colon